ALGS Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 21:44):
Our systems believe the stock currently is overvalued by -1.28% compare to its pairs and should correct downwards.

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases...

Stats
Dagens volum	240 340
Gjennomsnittsvolum	296 877
Markedsverdi	29.32M
EPS	$-0.220 ( Q1 \| 2024-05-07 )
Neste inntjeningsdato	( $-0.160 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.370 (Sector) 42.63 (Industry) 24.32
ATR14	$0.00500 (1.30%)

AADI -6.47%

ABCL 0.73%

ABCM 0.04%

ABEO -3.09%

ABIO -0.30%

ABOS 5.14%

ABSI 2.89%

ABUS -1.31%

ABVX -3.00%

ACAD -0.38%

ACER -17.95%

ACET -9.18%

ACGN 1.29%

ACHL -1.70%

ACHV 2.80%

ACIU -0.25%

ACLX -0.56%

ACRV -4.79%

ACST -3.58%

ACXP 3.69%

ADAG 7.14%

ADAP -4.13%

ADGI 0.87%

ADIL -3.68%

ADMA -1.09%

ADPT 0.15%

ADTX -3.47%

ADVM 1.16%

ADXN -1.60%

AEON -4.67%

AEZS -2.49%

AFMD -2.97%

AGEN -4.04%

AGIO -2.57%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 8.48%

AKRO -2.68%

AKTX -5.23%

AKUS 0.00%

ALBO 0.00%

ALDX -2.10%

ALEC -0.57%

ALGS -3.03%

ALKS 1.82%

ALLK -11.06%

ALLO -4.17%

ALLR -1.49%

ALNA 3.16%

ALNY 2.34%

ALPN 0.02%

ALPX 0.00%

ALRN -1.67%

ALT -15.85%

ALVR -1.00%

ALXN 0.00%

ALXO -11.34%

ALZN 5.10%

AMRN -2.51%

AMTI -3.13%

ANAB 1.34%

ANEB 7.95%

ANGN 0.00%

ANIX -3.64%

ANL -0.14%

ANNX 4.04%

ANPC -3.15%

APGE 1.55%

APGN 8.48%

APGNW 30.65%

APLM -5.86%

APLS 0.00%

APLT 1.13%

APM 1.47%

APOP 0.38%

APRE -3.13%

APTO 0.62%

APTX 3.17%

APVO 0.38%

ARAV -13.39%

ARCT -6.59%

ARDS -12.13%

ARDX 2.00%

ARGX -0.56%

ARNA 0.00%

ARPO -0.90%

ARQT -2.03%

ARTL -2.50%

ARTLW 0.00%

ARVN 7.09%

ARWR -2.42%

ASLN -4.68%

ASMB -5.55%

ASND -2.26%

ATAI -3.32%

ATHA 6.85%

ATHE 0.08%

ATHX -33.50%

ATNF 2.18%

ATOS 5.37%

ATRA -5.91%

ATXI 2.68%

ATXS -0.67%

AUPH -0.90%

AURA 4.78%

AUTL -3.59%

AVBP -3.24%

AVEO 0.00%

AVIR -1.60%

AVRO -1.41%

AVTE -0.69%

AVTX -3.67%

AVXL -5.56%

AXLA 0.00%

AXSM -1.46%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 1.45%

BCAB -7.19%

BCDA -0.85%

BCDAW -41.77%

BCEL 0.00%

BCLI 3.09%

BCRX 1.89%

BCTX 13.39%

BCTXW 13.02%

BCYC 1.22%

BDRX -4.63%

BDTX 0.11%

BEAM 2.68%

BFRA -2.91%

BGNE -3.01%

BIOR -4.46%

BIVI 2.13%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -2.21%

BLTE -1.44%

BLU 0.03%

BLUE -4.94%

BMEA -15.07%

BMRN 0.21%

BNOX 4.46%

BNTC -3.06%

BNTX -1.94%

BOLD -11.51%

BOLT -0.19%

BPMC -2.15%

BPTH -4.05%

BPTS -13.47%

BRNS -0.37%

BRTX -3.77%

BTAI 14.83%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 1.70%

CABA 0.55%

CADL 0.88%

CALA 0.00%

CALC -10.43%

CALT -1.59%

CAPR -0.43%

CARA -11.45%

CARM 7.39%

CASI 3.86%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.22%

CCCC -2.23%

CCXI 0.00%

CDAK 0.00%

CDIO -4.88%

CDIOW 24.00%

CDMO -1.41%

CDMOP 0.04%

CDT -4.88%

CDTTW -39.60%

CDTX -6.28%

CDXC 9.43%

CDXS 9.48%

CELC -3.58%

CELU 0.74%

CELUW 11.80%

CERC -1.68%

CERE -1.53%

CERO -4.95%

CEROW -10.18%

CFRX -27.95%

CGEM -0.49%

CGEN -3.59%

CGON -2.94%

CGTX -3.98%

CHMA -6.00%

CHRS 5.06%

CINC 0.00%

CING 0.34%

CINGW 34.95%

CKPT -0.48%

CLBS -16.75%

CLDX -0.69%

CLGN -0.60%

CLLS -3.11%

CLNN -1.39%

CLNNW 0.00%

CLRB 6.32%

CLSD -3.34%

CLSN -0.68%

CLVS 0.00%

CMMB -2.94%

CMND 3.23%

CMPI 0.00%

CMPX 1.89%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.55%

CNCE 0.00%

CNSP -33.10%

CNST 0.00%

CNTA 0.31%

CNTB -1.50%

CNTX -5.25%

COCP -1.41%

COEPW 32.45%

COGT -2.71%

CORT 3.29%

COYA 0.49%

CPRX -1.62%

CRBP -1.90%

CRBU -7.93%

CRDF 1.99%

CRGX -0.70%

CRIS -2.64%

CRNX -5.95%

CRSP 1.14%

CRTX 2.63%

CRVO -3.53%

CRVS 0.28%

CSBR -0.20%

CTCX 1.20%

CTIC 0.06%

CTMX -4.55%

CTNM 3.86%

CTXR -4.48%

CUE -2.43%

CVAC -5.86%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 17.64%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.57%

CYTO 0.87%

DARE 0.86%

DAWN -0.30%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 29.33%

DNLI -2.05%

DNTH -2.97%

DOMH 1.06%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG -0.10%

DSGN -2.57%

DTIL -0.21%

DYAI 9.68%

EARS -1.77%

EDIT -3.22%

EDSA 4.14%

EFTR 3.60%

EFTRW -51.85%

EIGR -9.21%

ELAB -3.01%

ELDN 7.56%

ELEV -2.28%

ELOX 10.77%

ELTX -3.38%

ELVN -0.37%

ELYM 4.81%

ENGN 0.49%

ENGNW -21.67%

ENLV -1.45%

ENOB 1.79%

ENSC 6.55%

ENTA -1.06%

ENTO -4.97%

ENTX 0.53%

ENVB -0.02%

EPIX -2.68%

EPRX -2.30%

EPZM 0.00%

EQ -1.24%

EQRX -2.09%

EQRXW 0.00%

ERAS 4.81%

ERNA -2.78%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -6.03%

ETON 2.59%

ETTX 0.00%

EVAX -2.14%

EVGN 2.77%

EVLO 0.00%

EWTX -0.06%

EXAI -0.57%

EXEL 0.61%

EYEG -0.69%

EYEN 0.00%

EYPT 0.06%

FATE -12.23%

FBIO 0.59%

FBIOP 0.87%

FBLG -10.70%

FBRX -0.02%

FDMT -5.18%

FENC -2.66%

FGEN -9.83%

FHTX 9.75%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.82%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.89%

FULC 3.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -1.12%

GANX -0.84%

GBIO -1.07%

GBT 0.01%

GDTC 0.50%

GERN -1.44%

GHRS -4.31%

GLMD -3.02%

GLPG -1.87%

GLSI 9.23%

GLTO -3.90%

GLUE -2.53%

GLYC -14.59%

GMAB -0.35%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.34%

GNLX -5.31%

GNPX -4.41%

GNTA 3.94%

GOSS -8.50%

GOVX -5.00%

GOVXW 10.89%

GPCR -6.96%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -2.14%

GRTX -1.66%

GTHX 3.64%

GUTS -0.23%

GXGXW 41.67%

GYRE -6.30%

HALO -1.04%

HARP 0.09%

HCWB -10.05%

HEPA -3.50%

HGEN -84.62%

HILS 5.66%

HLVX -0.84%

HOOK 2.03%

HOTH -0.82%

HOWL 0.43%

HRMY 2.08%

HRTX 8.69%

HSTO 0.00%

HUMA 1.01%

HUMAW -6.25%

IBRX -6.88%

ICCC -2.10%

ICPT 0.21%

ICU 18.41%

ICUCW 4.86%

ICVX -0.91%

IDRA -23.04%

IDYA -3.35%

IFRX -3.08%

IGMS -1.41%

IKNA -0.90%

IKT 0.00%

IMAB -0.29%

IMCR -3.50%

IMGN 0.02%

IMGO 0.00%

IMMP 5.50%

IMMX -5.60%

IMNM 3.81%

IMNN 1.77%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -4.17%

IMTX -1.25%

IMTXW 6.00%

IMUX -1.87%

IMV 0.00%

IMVT -3.63%

INAB -1.68%

INBX -2.72%

INCY -1.98%

INDP 6.88%

INFI -52.38%

INKT -0.46%

INM 3.18%

INMB 3.78%

INO 2.21%

INSM -0.69%

INTS -3.73%

INVA 0.74%

INZY 1.49%

IOBT -7.11%

IONS 1.52%

IOVA -3.97%

IPA 0.03%

IPHA 4.28%

IPSC -2.34%

IRON -2.02%

ISEE 0.38%

ITOS 2.80%

ITRM 1.52%

IVA 6.96%

IVVD 0.41%

JAGX 0.52%

JANX -4.92%

JAZZ -0.93%

JNCE 0.00%

JSPR -2.11%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.47%

KALV -2.51%

KDNY 0.22%

KMPH -0.34%

KNSA -2.32%

KNTE -0.38%

KOD -9.09%

KPRX -5.76%

KPTI -8.85%

KRBP -10.00%

KRON 1.61%

KROS -0.45%

KRRO -2.12%

KRTX 0.03%

KRYS 0.76%

KTRA 10.39%

KTTA -0.65%

KTTAW 0.92%

KURA 0.49%

KYMR -3.53%

KYTX -5.30%

KZIA 7.51%

KZR -1.75%

LABP 0.57%

LBPH 0.05%

LBPS 0.00%

LBPSW 14.81%

LEGN 2.92%

LENZ -2.88%

LEXX 0.59%

LEXXW -14.63%

LGND -0.92%

LGNDV 0.00%

LGVN -9.84%

LIAN -8.28%

LIFE 2.70%

LIPO -5.29%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 0.61%

LPCN -4.36%

LPTX -2.75%

LQDA 0.41%

LRMR -1.35%

LSTA -1.68%

LTRN 6.00%

LUMO 0.67%

LVTX -4.59%

LXEO -12.46%

LXRX -2.06%

LYEL -35.29%

LYRA 4.30%

MACK 0.10%

MBIO -9.42%

MBRX -1.43%

MCRB 1.61%

MDGL -1.92%

MDNA -13.16%

MDWD 3.18%

MDXG -1.69%

MEIP 0.70%

MESO -1.63%

MGNX -5.22%

MGTA -7.74%

MGTX -0.71%

MGX -0.54%

MIRM -0.57%

MIRO 0.59%

MIST 3.08%

MITO 0.00%

MLEC -6.54%

MLECW 2.31%

MLND -5.36%

MLTX 0.83%

MLYS -7.48%

MNKD -0.86%

MNMD 3.04%

MNOV 1.41%

MNPR -8.59%

MOLN 0.76%

MOR 0.62%

MORF -3.10%

MREO 0.00%

MRKR -0.43%

MRNA -10.35%

MRNS -6.25%

MRSN -4.05%

MRTX -0.17%

MRUS 0.39%

MRVI 0.51%

MTCR -1.29%

MTEM 7.67%

MTP -18.50%

MURA -4.00%

MYMD 1.08%

NAMS 0.08%

NAMSW 0.64%

NAUT 0.23%

NBRV 0.71%

NBSE -1.56%

NBTX 8.91%

NCNA -0.18%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 4.50%

NKGN 10.92%

NKGNW -20.00%

NKTR 1.40%

NKTX -2.20%

NLSP 2.88%

NLSPW 26.67%

NMRA -0.97%

NMTR -42.97%

NOVN -24.84%

NRBO 15.02%

NRIX -1.42%

NRSN 0.80%

NRSNW 0.00%

NRXP -8.79%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -4.82%

NTRBW -31.07%

NUVL -2.00%

NVAX -6.28%

NVCT -8.45%

NVIV -34.28%

NXTC -5.88%

NYMX -0.05%

OABI 3.43%

OABIW -10.06%

OBIO 1.46%

OBSV 0.00%

OCEA -4.23%

OCGN 7.17%

OCS -1.00%

OCUL 0.46%

OCUP 0.00%

ODT -4.27%

OKYO 1.72%

OLMA -4.69%

OMER -1.80%

OMGA -2.08%

ONCO 6.37%

ONCR -3.08%

ONCS 31.87%

ONCT -2.04%

ONCY 2.49%

ONTX -0.47%

ONVO 3.72%

OPNT 0.00%

OPT -5.15%

ORGS -0.69%

ORIC -1.93%

ORMP 16.29%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -0.83%

OVID 0.21%

OYST 0.00%

PALI -0.48%

PASG 0.88%

PBLA -7.50%

PBM -3.44%

PBYI 4.05%

PCSA 0.00%

PCVX 0.98%

PDSB -5.70%

PEPG 1.31%

PGEN -6.29%

PHAR 1.99%

PHAS 0.00%

PHAT 0.00%

PHIO -3.55%

PHIOW 36.47%

PHVS -6.48%

PHXM -5.20%

PIRS -0.34%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.93%

PLUR 10.75%

PMN -5.55%

PMVP -2.08%

PNT 0.16%

PPBT -2.98%

PRAX 5.20%

PRDS 0.93%

PRLD -3.43%

PROG -3.47%

PROK 1.35%

PRQR 0.60%

PRTA -3.08%

PRTC 0.49%

PRTG 1.40%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -12.20%

PSTX -4.26%

PTCT -0.60%

PTE -0.82%

PTGX 0.32%

PTIXW -48.41%

PULM 1.56%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -5.56%

QNCX 2.23%

QNRX 0.87%

QSI -30.42%

QSIAW -9.44%

QTTB 2.91%

QURE -1.35%

RAIN -1.63%

RANI 4.28%

RAPT -2.11%

RARE 1.93%

RCKT -10.31%

REGN -0.22%

RENB -4.04%

REPL -2.95%

RETA 0.02%

REUN -0.89%

REVB -1.67%

REVBU 3.46%

REVBW 5.00%

RGLS -5.62%

RGNX -6.37%

RIGL -6.24%

RLAY -5.74%

RLMD 0.33%

RLYB -5.03%

RNA 1.94%

RNAC -2.60%

RNAZ -1.94%

RNXT 2.23%

ROIV -2.12%

ROIVW 4.56%

RPHM -2.17%

RPRX -0.89%

RPTX -1.47%

RUBY 2.70%

RVLP -32.05%

RVMD -0.44%

RVMDW -29.90%

RVNC 0.21%

RVPH -0.40%

RVPHW -5.28%

RXDX 0.09%

RXRX -6.02%

RYTM -6.06%

RYZB 0.02%

RZLT 2.85%

SABS -1.37%

SABSW -5.53%

SAGE -0.60%

SANA -2.12%

SAVA -3.39%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.10%

SCPH 10.86%

SCPS 0.00%

SEEL -4.78%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -4.41%

SGMT -5.31%

SGTX -2.56%

SIOX 22.63%

SLDB -3.28%

SLGL 5.23%

SLN -8.22%

SLNO 0.62%

SLRX 0.41%

SLS -3.00%

SMMT -3.37%

SNDX 1.74%

SNGX 3.40%

SNPX -0.69%

SONN 0.54%

SPPI -0.49%

SPRB -1.68%

SPRC -3.29%

SPRO 0.37%

SRNE 0.00%

SRPT -1.21%

SRRA 0.00%

SRRK -1.55%

SRZN -2.45%

STAB 0.00%

STOK -6.88%

STRO -3.02%

STSA 0.00%

STTK 6.33%

SURF -0.93%

SVRA -3.82%

SWTX -0.14%

SYBX 0.00%

SYRS -1.98%

TALS -0.73%

TARA -10.24%

TARS -2.29%

TBPH 0.24%

TCBP 5.49%

TCDA 0.00%

TCON -0.70%

TCRR 0.00%

TCRT 4.59%

TCRX -1.62%

TECH -1.48%

TENX -0.32%

TERN -7.45%

TFFP -11.28%

TGTX -8.13%

THRX 0.12%

TIL -1.22%

TLC 0.00%

TLSA -4.53%

TNGX -3.35%

TNXP -10.10%

TNYA -5.08%

TPST 5.58%

TRDA -5.01%

TRVI 1.92%

TRVN 3.19%

TSHA -18.46%

TSVT -3.75%

TTNP -6.05%

TVTX 3.89%

TYRA -7.24%

UBX -2.13%

UNCY -4.19%

URGN 3.12%

UTHR -0.29%

VACC 11.36%

VALN -2.96%

VAXX 126.67%

VBIV -0.81%

VBLT -8.77%

VCEL 1.57%

VCNX 9.36%

VCYT -0.97%

VERA -4.34%

VERU 1.30%

VERV -3.54%

VIGL 0.54%

VINC 2.81%

VIR -1.03%

VIRI -5.66%

VIRX 3.85%

VKTX -1.68%

VLON -13.04%

VNDA -3.01%

VOR -6.05%

VRCA 2.06%

VRDN -3.49%

VRNA -2.02%

VRPX 3.58%

VRTX -0.04%

VSTM 4.77%

VTGN -2.11%

VTVT 1.28%

VTYX -1.88%

VXRT -1.09%

VYGR -0.77%

VYNE -5.80%

VYNT 7.78%

WINT -2.72%

WVE -8.49%

XBIO 1.03%

XBIT 5.63%

XCUR 0.23%

XENE -0.85%

XERS 5.04%

XFOR 6.28%

XLO 3.38%

XLRN 0.00%

XNCR -0.05%

XOMA -7.72%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.87%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -2.92%

ZNTL -1.31%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-03-01	Mcclure Matthew W.	Buy	72 000	Stock Option (Right to Buy)
2024-03-01	Calhoun Lesley Ann	Buy	308 940	Stock Option (Right to Buy)
2024-03-01	Symons Julian A.	Buy	72 000	Stock Option (Right to Buy)
2024-03-01	Blatt Lawrence	Buy	965 435	Stock Option (Right to Buy)
2024-02-28	Hirth Peter	Buy	4 411	Stock Option (Right to Buy)

INSIDER POWER
81.91
Last 96 transactions
Buy: 18 924 669 \| Sell: 1 675 487

Korrelasjon (AI algo v.1.1b): Overvalued: -1.28% $0.391 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: 0.06 (neutral)

Kort: -0.60 (weak negative)

Signal:(44.57) Neutral

Aligos Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner
OZEM	1
ENTO	0.935
FIMSX	0.86
IIXIX	0.859
MWFRX	0.854
NALFX	0.854
EFRA	0.845
BRKR	0.842
HCSG	0.842
ATGL	0.842

10 Mest negative korrelasjoner
PLTNU	-0.881
CLMB	-0.856
AGMI	-0.852
AAPD	-0.835
NMFCZ	-0.835
NWTN	-0.834
PXMD	-0.834
CGON	-0.814
HTOOW	-0.807
BRLSW	-0.804

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Aligos Therapeutics, Inc. Korrelasjon - Valuta/Råvare

-0.20
( neutral )

0.46
( neutral )

0.00
( neutral )

0.37
( neutral )

Aligos Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$15.53M
Bruttogevinst:	$12.46M (80.24 %)
EPS:	$-1.360

FY	2023
Omsetning:	$15.53M
Bruttogevinst:	$12.46M (80.24 %)
EPS:	$-1.360

FY	2022
Omsetning:	$13.91M
Bruttogevinst:	$10.23M (73.57 %)
EPS:	$-2.25

FY	2021
Omsetning:	$4.36M
Bruttogevinst:	$4.36M (100.00 %)
EPS:	$-3.22

Financial Reports:

No articles found.

Aligos Therapeutics, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The company also develops ALG-020572, an antisense oligonucleotide to prevent HBsAg translation and secretion; and ALG-055009, a small molecule THR-ß agonist that is in the Phase 1a/1b for the treatment of non-alcoholic steatohepatitis(NASH). In addition, it develops siRNA drug candidate, ALG-125755, as well as ALG-125097 and ALG-125819, demonstrated potent inhibition of HBsAg release from HBV-infected cells. It has entered into license and collaboration agreements with Luxna Biotech Co., Ltd. to develop and commercialize products containing oligonucleotides targeting hepatitis B virus genome; Emory University to provide hepatitis B virus capsid assembly modulator technology; research, licensing, and commercialization agreement with Katholieke Universiteit Leuven to develop coronavirus protease inhibitors; and Merck to discover, research, optimize, and develop oligonucleotides directed against a NASH. The company was incorporated in 2018 and is headquartered in South San Francisco, California.